CP and neoplasm: Antibiotics targeting gram-positive bacteria significantly reduce the efficacy of CP (Wang et al., 2019), suggesting that gram-positive bacteria, such as Enterococcus and Lactobacillus, are key in modulating the anti-tumor efficacy of CP against hematological tumors.